Abstract
Stenotrophomonas maltophilia isolate CF13 is a multidrug-resistant isolate that was recovered in Sydney, Australia, in 2011, from a sputum sample from an individual with cystic fibrosis. The genome sequence of CF13 was completed using long- and short-read technologies.
Highlights
Stenotrophomonas maltophilia isolate CF13 is a multidrug-resistant isolate that was recovered in Sydney, Australia, in 2011, from a sputum sample from an individual with cystic fibrosis
The complete genome sequence shows that CF13 belongs to a novel sequence type (ST) of S. maltophilia, namely, ST371
CF13 was found to be clustered with the reference strain K279a (Fig. 1)
Summary
Stenotrophomonas maltophilia isolate CF13 is a multidrug-resistant isolate that was recovered in Sydney, Australia, in 2011, from a sputum sample from an individual with cystic fibrosis. Method and program that were validated previously [10]. The chromosome, consisting of 4,591,696 bases with a GC content of 66.46%, was annotated using the NCBI Prokaryotic Genome Annotation Pipeline (v.4.11) [11].
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
